Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.76 EUR 0.27% Market Closed
Market Cap: 33.9m EUR
Have any thoughts about
Genoway SA?
Write Note

Genoway SA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genoway SA
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Genoway SA
PAR:ALGEN
Cash from Operating Activities
€6.9m
CAGR 3-Years
N/A
CAGR 5-Years
144%
CAGR 10-Years
26%
Valneva SE
PAR:VLA
Cash from Operating Activities
-€142.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Cash from Operating Activities
-€41.5m
CAGR 3-Years
19%
CAGR 5-Years
10%
CAGR 10-Years
-12%
Inventiva SA
PAR:IVA
Cash from Operating Activities
-€84.7m
CAGR 3-Years
-25%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Cash from Operating Activities
€26.8m
CAGR 3-Years
-32%
CAGR 5-Years
68%
CAGR 10-Years
N/A
OSE Immunotherapeutics SA
PAR:OSE
Cash from Operating Activities
€58.4m
CAGR 3-Years
N/A
CAGR 5-Years
49%
CAGR 10-Years
N/A
No Stocks Found

Genoway SA
Glance View

Market Cap
32.8m EUR
Industry
Biotechnology

genOway SA engages in the development of genetically-modified mouse, rat, and cellular models for biopharmaceutical and research companies. The company is headquartered in Lyon, Auvergne-Rhone-Alpes. The company went IPO on 2007-05-04. The firm offers an array of services which include site specific transgenesis, random insertion based transgenic models, gene overexpression, humanization, gene deletion and gene knock-down (RNA interference). The Company’s clients include multinational biopharmaceutical companies, such as Roche, Novartis and Servier, as well as universities and research institutes, notably Boston University, University of Tokyo, Johann Wolfgang Goethe University Hospital Frankfurt and Centre National de Genotypage.

ALGEN Intrinsic Value
5.11 EUR
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Genoway SA's Cash from Operating Activities?
Cash from Operating Activities
6.9m EUR

Based on the financial report for Jun 30, 2024, Genoway SA's Cash from Operating Activities amounts to 6.9m EUR.

What is Genoway SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
26%

Back to Top